4//SEC Filing
Plavsic Mark 4
Accession 0000950170-24-115150
CIK 0001501796other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 9:25 PM ET
Size
16.9 KB
Accession
0000950170-24-115150
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technology Officer
Transactions
- Sale
Common Stock
2024-10-16$9.85/sh−7,383$72,723→ 121,132 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001868719
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 9:25 PM ET
- Size
- 16.9 KB